Related references
Note: Only part of the references are listed.Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men
S. R. Gray et al.
CELL STRESS & CHAPERONES (2008)
Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARα and UCP2 expression in rats
Anna G. Holmes et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle
Stephan Glund et al.
DIABETES (2007)
IL-6 increases muscle insulin sensitivity only at superphysiological levels
Paige C. Geiger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle
Lubna Al-Khalili et al.
MOLECULAR ENDOCRINOLOGY (2006)
IL6 gene promoter polymorphisms and type 2 diabetes -: Joint analysis of individual participants' data from 21 studies
Cornelia Huth et al.
DIABETES (2006)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Rikke Krogh-Madsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome
Eduardo Esteve et al.
CLINICAL ENDOCRINOLOGY (2006)
Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects
MK Heliövaara et al.
DIABETES OBESITY & METABOLISM (2005)
Physical activity and modulation of systemic low-level inflammation
H Bruunsgaard
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation
P Plomgaard et al.
DIABETES (2005)
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt
C Weigert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo
HJ Kim et al.
DIABETES (2004)
AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise
M Kelly et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects
V Rotter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
AMP-activated protein kinase and muscle glucose uptake
N Musi et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2003)
Skeletal muscle interleukin-6 and tumor necrosis factor-α release in healthy subjects and patients with type 2 diabetes at rest and during exercise
MA Febbraio et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans
A Steensberg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Interleukin-6 gene polymorphism and insulin sensitivity
JM Fernandez-Real et al.
DIABETES (2000)
Share Paper
